Idarucizumab
- IVIdarucizumabPraxbind
- Mechanism of Action
- A monoclonal antibody that strongly binds to dabigatran, preventing its effect on prothrombin.
Clinical Use
- Indications
- Adverse Effects
- No specific adverse reactions identified in clinical trials.